US Import Tariffs: With 25% Threat, Indian Industry Reads Between Trump Lines
About Half Of Generics Supply From India
US President Trump’s threat of a “25% or higher” import tariff on pharmaceuticals sends ripples through an already uncertain environment. With about half of generics sourced from India, captains of industry read between the lines
